Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
58.40
+3.53 (6.43%)
At close: Sep 26, 2025, 4:00 PM EDT
58.34
-0.06 (-0.11%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $544.83M in the quarter ending June 30, 2025, with 72.61% growth. This brings the company's revenue in the last twelve months to $2.01B, up 88.69% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$2.01B
Revenue Growth
+88.69%
P/S Ratio
6.40
Revenue / Employee
$1,230,017
Employees
1,637
Market Cap
13.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 693.15B |
Costco Wholesale | 275.24B |
PepsiCo | 91.75B |
The Procter & Gamble Company | 84.28B |
Unilever | 70.19B |
Anheuser-Busch InBev | 58.52B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 39.06B |
HIMS News
- 2 days ago - Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks - Seeking Alpha
- 2 days ago - Hims & Hers Powers YieldMax's Latest Options-Based Income ETF - Benzinga
- 9 days ago - Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - PRNewsWire
- 10 days ago - Hims & Hers Health: Bumpy Ride Will End - Seeking Alpha
- 10 days ago - Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga
- 12 days ago - Trump Drug Ad Crackdown: FDA Warns Novo Nordisk, Eli Lilly, Hims - Forbes
- 12 days ago - FDA Warns Hims Over Ads About Compounded Weight-Loss Drugs - Forbes
- 12 days ago - Hims & Hers shares drop 6% after FDA warning on semaglutide marketing claims - Invezz